TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Swedish Pharma Compliance AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
42
|
49
|
72 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
14
|
12
|
45 |
| EBITDA |
14
|
11
|
45 |
| Total assets |
157
|
169
|
175 |
| Current assets |
66
|
75
|
103 |
| Current liabilities |
11
|
12
|
9 |
| Equity capital |
146
|
157
|
165 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
93.0%
|
92.9%
|
94.3% |
| Turnover per employee |
42
|
49
|
72 |
| Profit as a percentage of turnover |
33.3%
|
24.5%
|
62.5% |
| Return on assets (ROA) |
8.9%
|
7.1%
|
25.7% |
| Current ratio |
600%
|
625.0%
|
1144.4% |
| Return on equity (ROE) |
9.6%
|
7.6%
|
27.3% |
| Change turnover |
-5
|
-23
|
-1 |
| Change turnover % |
-11%
|
-33%
|
-1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.